GlassScriptPhysician profile
Morgan Renee Leblanc
NPI 1245986215
$6,898.94
in general payments reported to CMS, 2019-2025
40 companies · $2,857 in 2025
The $2,857 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $604 · 2023: $1,514 · 2024: $1,924 · 2025: $2,857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,195 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,195.32 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,425.07 | 2022-2025 | |
| Lilly USA, LLC | $729.19 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Astellas Pharma US INC | $511.60 | 2023-2025 | Veozah, Myrbetriq |
| Phathom Pharmaceuticals, INC. | $473.23 | 2024-2025 | Voquezna |
| Novo Nordisk INC | $442.01 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $359.32 | 2022-2025 | Jardiance, Tradjenta, Synjardy |
| Pfizer INC. | $297.48 | 2023-2025 | |
| Amgen INC. | $293.55 | 2022-2025 | Evenity, Prolia, Prolia |
| Abbott Laboratories | $250.89 | 2023-2025 | Freestyle Libre 3, Mitraclip, Freestyle Libre |
| Axsome Therapeutics, INC. | $193.69 | 2024-2025 | Auvelity |
| Sumitomo Pharma America, INC. | $174.55 | 2023-2025 | Gemtesa |
| Glaxosmithkline, LLC. | $154.22 | 2022-2025 | Arexvy, Shingrix |
| Janssen Biotech, INC. | $146.19 | 2025 | |
| Merck Sharp & Dohme LLC | $134.26 | 2022-2024 | Gardasil 9, Gardasil, Capvaxive |
| Kyowa Kirin, INC. | $118.37 | 2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $100.00 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.24 | 2022-2025 | Xifaxan, Trulance |
| Genzyme Corporation | $93.26 | 2023-2024 | |
| Lundbeck LLC | $87.39 | 2022-2025 | Vyepti |
| Bayer Healthcare Pharmaceuticals INC. | $86.23 | 2023-2025 | |
| Upsher-Smith Laboratories LLC | $83.07 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $78.30 | 2025 | |
| Millicent US INC | $56.97 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Exact Sciences Corporation | $56.18 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $47.98 | 2022-2023 | Trintellix |
| Currax Pharmaceuticals LLC | $44.92 | 2022-2024 | Contrave, Onzetra Xsail |
| Idorsia Pharmaceuticals US INC | $43.96 | 2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $42.54 | 2022-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $41.68 | 2024 | Spravato |
| Dexcom, INC. | $37.93 | 2025 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $30.21 | 2022 | |
| Hologic Sales and Service, LLC | $28.77 | 2024 | Affirm Prone Biopsy System |
| Radius Health, INC. | $24.71 | 2025 | Tymlos |
| Intra-Sana Laboratories | $18.99 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Acadia Pharmaceuticals INC | $18.89 | 2025 | Daybue |
| Collegium Pharmaceutical, INC. | $16.98 | 2022 | |
| Sanofi Pasteur INC. | $16.54 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.94 | 2022 | |
| Amneal Pharmaceuticals LLC | $14.25 | 2025 | Unithroid |
| Tris Pharma INC | $13.39 | 2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Leblanc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.